These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators. Halpin DM; Kaplan AG; Russell RK Respir Med; 2017 Jul; 128():28-41. PubMed ID: 28610667 [TBL] [Abstract][Full Text] [Related]
9. Tiotropium – what role in asthma? Drug Ther Bull; 2015 Sep; 53(9):102-4. PubMed ID: 26358316 [TBL] [Abstract][Full Text] [Related]
10. Benefits of Tiotropium/Olodaterol Compared with Tiotropium in Patients with COPD Receiving only LAMA at Baseline: Pooled Analysis of the TONADO Buhl R; Singh D; de la Hoz A; Xue W; Ferguson GT Adv Ther; 2020 Aug; 37(8):3485-3499. PubMed ID: 32462607 [TBL] [Abstract][Full Text] [Related]
11. Tiotropium increases PPARγ and decreases CREB in cells isolated from induced sputum of COPD patients. Holownia A; Mroz RM; Skopinski T; Kolodziejczyk A; Chyczewska E; Braszko JJ Adv Exp Med Biol; 2013; 756():9-14. PubMed ID: 22836613 [TBL] [Abstract][Full Text] [Related]
12. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Keam SJ; Keating GM Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163 [TBL] [Abstract][Full Text] [Related]
13. Affirmation of the adoration of the vagi and role of tiotropium in asthmatic patients. Gelb AF; Nadel JA J Allergy Clin Immunol; 2016 Oct; 138(4):1011-1013. PubMed ID: 27527265 [No Abstract] [Full Text] [Related]
15. [Muscarinic cholinergic receptor antagonists enhanced the expression of CD(8)(+)CD(25)(+)Foxp(3)(+) regulatory T cells in stable COPD patients]. Zhang JC; Wang P; Xiong XZ; Deng L; Xin JB; Ma WL; Shi HZ Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):33-6. PubMed ID: 20368022 [TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs. Casarosa P; Bouyssou T; Germeyer S; Schnapp A; Gantner F; Pieper M J Pharmacol Exp Ther; 2009 Aug; 330(2):660-8. PubMed ID: 19478135 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of Tiotropium/Olodaterol Compared with Tiotropium as a First-Line Maintenance Treatment in Patients with COPD Who Are Naïve to LAMA, LABA and ICS: Pooled Analysis of Four Clinical Trials. Buhl R; de la Hoz A; Xue W; Singh D; Ferguson GT Adv Ther; 2020 Oct; 37(10):4175-4189. PubMed ID: 32671684 [TBL] [Abstract][Full Text] [Related]
18. Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. Gupta V; Singh D Expert Rev Respir Med; 2012 Dec; 6(6):581-8. PubMed ID: 23234445 [TBL] [Abstract][Full Text] [Related]
19. Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease. Buhl R; Magder S; Bothner U; Tetzlaff K; Voß F; Loaiza L; Vogelmeier CF; McGarvey L Respir Med; 2017 Jan; 122():58-66. PubMed ID: 27993292 [TBL] [Abstract][Full Text] [Related]